Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_assertion type Assertion NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_head.
- NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_assertion description "[During the median follow-up time of 57 months, 350 children developed at least one persistent IA (GAD antibody, IA-2A, or micro insulin autoantibodies) and 84 of them progressed to T1D.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_provenance.
- NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_assertion evidence source_evidence_literature NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_provenance.
- NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_assertion SIO_000772 25422107 NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_provenance.
- NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_assertion wasDerivedFrom befree-2016 NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_provenance.
- NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_assertion wasGeneratedBy ECO_0000203 NP1239741.RA4Ihpw2JDOGVOJJ8pmH5HxNFZE4WcG1RL1tzezBNQOgc130_provenance.